Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.4000
-0.1199 (-23.06%)
Nov 9, 2026, 2:00 PM EST
Cell Source Market Cap
Cell Source has a market cap or net worth of $27.54 million as of November 9, 2026. It is the 32,363rd most valuable company in the world and the 4,793rd biggest in the United States. Its market cap has increased by 46.56% in one year.
Market Cap
27.54M
Enterprise Value
38.36M
Revenue
n/a
Global Rank
Country Rank
#4,793 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since July 1, 2014, Cell Source's market cap has decreased from 36.03M to 27.54M, a decrease of -23.56%. That is a compound annual growth rate of -2.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 28.95M | 18.58% |
| Dec 31, 2025 | 24.41M | 59.96% |
| Dec 31, 2024 | 15.26M | -14.98% |
| Dec 27, 2023 | 17.95M | -40.09% |
| Dec 29, 2022 | 29.96M | -30.67% |
| Dec 31, 2021 | 43.22M | -32.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 92.36M |
| Vaxart | 89.98M |
| ProText Mobility | 66.81M |
| Nuo Therapeutics | 51.82M |
| Sangamo Therapeutics | 47.23M |
| Arch Biopartners | 42.12M |
| ZIVO Bioscience | 33.71M |
| Provectus Biopharmaceuticals | 22.27M |